The next P3 EQUATE Quarterly Network Meeting will take place on 12/3/24 at 3:30pm CST. Dr. Rebecca Hamm will present “Implementation Science to Advance Equity in Maternal and Infant Health Outcomes.” Register in advance for this meeting: https://uab.zoom.us/meeting/register/tZMsd-Gvrz0uGNY4bI3mcX0sByrherls08gN…
CCTS expeDITIons: Training Grants and Pilot Funding in Dissemination, Implementation, and Adjacent Sciences
November 12, 2024; 3-4:30 PM
P3 EQUATE and P3OPPY were represented at the November 2024 CCTS Expeditions session at UAB. The theme of this session was “Training Grants and Pilot Funding in Dissemination, Implementation, and Adjacent Sciences.”
The next P3 EQUATE Quarterly Network Meeting will take place on 12/3/24 at 3:30pm CST. Dr. Rebecca Hamm will present “Implementation Science to Advance Equity in Maternal and Infant Health Outcomes.” Register in advance for this meeting: https://uab.zoom.us/meeting/register/tZMsd-Gvrz0uGNY4bI3mcX0sByrherls08gN
On Saturday November 2, join Sadiya S. Khan, MD, MSc (@HeartDocSadiya), for the 7th Annual SCCT Cardiovascular Disease Prevention Symposium, where she will be presenting, “Do risk scores work in young individuals? Which one should we use?” http://scct.org/page/2024PrevSymp
P3 Equate was well represented at the AHA network meetings in Irving TX. Proud of the teamwork by OSU, UAB, NW, UNC, Penn, NCA&T and Connection Health supported by experts around the country, leveraging the $20M AHA investment to advance equity in maternal and infant health.
The P3 EQUATE Network, in partnership with the American Heart Association and collaborating centers, is pleased to announce its first cohort of pilot grant awardees. The EQUATE pilot equity research funds are intended to support impactful research that focuses on promoting health equity in maternal health outcomes across the United States. The RFA was designed to generate preliminary data for future federal and other grant applications and initiatives while encouraging interdisciplinary and multi-site collaborations. We anticipate additional pilot opportunities in the future.
CWRH Seminar: TODAY at 12:30pm (CST) . Dr. Bill Andrews will present: “From Meager Beginnings to a Powerhouse: The Expansion of Women’s Health at UAB.” Dr. Rachel Sinkey will present “Spotlight on Maternal and Infant Health Equity”. Register here: https://uab.zoom.us/meeting/register/tZEuc-GupzovGd3c62X3_UahVVpXAqt1yuFo#/registration
PROVIDENCE – Dr. William Grobman, a nationally recognized maternal-fetal medicine expert, has joined Care New England Health System and Brown University.
Beginning July 1, Grobman serves as Care New England’s chief scientific officer and the associate dean of research for the health system and Brown’s Warren Alpert Medical School. Grobman will also serve as the executive vice chair for the Department of Obstetrics and Gynecology beginning Dec. 1.
The Clinical Research (CR) Forum, a non-profit membership association of top clinical research experts and thought leaders from the nation’s leading academic health centers, presented the Distinguished Clinical Research Achievement Award to two outstanding studies at the Top Ten Clinical Research Achievement Awards on April 2nd at the Paris Hotel Las Vegas, and for the second year in a row, CCTS investigators were recognized for their achievements.
This year, the CRF awarded the study entitled “Azithromycin to Prevent Sepsis or Death in Women Planning a Vaginal Birth (A-PLUS),” led by Dr. Waldemar Carlo, Professor of Pediatrics, co-Division Director of Neonatology and Edwin M. Dixon Endowed Chair, and Dr. Alan Tita, Professor and Senior Vice Chair for research and innovation in UAB’s Obstetrics and Gynecology Department. The A-PLUS trial represents a landmark study with global reach enrolling more than 29,000 women in seven low- and middle-income countries with significant health disparities. Published in the New England Journal of Medicine in 2023, the project created an evidence base for a low-cost intervention that can be used to reduce maternal sepsis and deaths in underserved regions on a global scale.
The CR Forum presents its annual Top Ten Clinical Research Achievement Awards to highlight outstanding research advances that involve both innovation and impact on human diseases. A complete list of the 2024 Top Ten Award Winners can be found at www.clinicalresearchforum.org.
“This year’s award winners demonstrate the immense value of our nation’s investment in clinical research, and the direct impact of that work on the health of millions of people in the United States,” said Harry P. Selker, MD, MSPH, CR Forum Board Chair and Dean of the Clinical and Translational Science Institute at Tufts University. “For many, these innovative studies and related clinical trials may represent the only hope for surviving a life-threatening disease. They also pave the way to advance new therapies and treatments that improve public health.”
The Distinguished Clinical Research Achievement Award is presented to the top two studies that show creativity, innovation, or a novel approach that demonstrates an immediate impact on the health and well-being of patients. The study, “Azithromycin to Prevent Sepsis or Death in Women Planning a Vaginal Birth,” is one of this year’s honorees.
UAB is an Equal Employment/Equal Educational Opportunity Institution dedicated to providing equal opportunities and equal access to all individuals regardless of race, color, religion, ethnic or national origin, sex (including pregnancy), genetic information, age, disability, religion, sexual orientation, gender identity, gender expression, and veteran’s status. As required by Title IX, UAB prohibits sex discrimination in any education program or activity that it operates. Individuals may report concerns or questions to UAB’s Assistant Vice President and Senior Title IX Coordinator. The Title IX notice of nondiscrimination is located at uab.edu/titleix.